WO2012001083A3 - Novel eprinomectin injectable compositions - Google Patents
Novel eprinomectin injectable compositions Download PDFInfo
- Publication number
- WO2012001083A3 WO2012001083A3 PCT/EP2011/060969 EP2011060969W WO2012001083A3 WO 2012001083 A3 WO2012001083 A3 WO 2012001083A3 EP 2011060969 W EP2011060969 W EP 2011060969W WO 2012001083 A3 WO2012001083 A3 WO 2012001083A3
- Authority
- WO
- WIPO (PCT)
- Prior art keywords
- eprinomectin
- novel
- solvents
- injectable compositions
- parasiticide
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
- A61K31/365—Lactones
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
- A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
- A61K47/10—Alcohols; Phenols; Salts thereof, e.g. glycerol; Polyethylene glycols [PEG]; Poloxamers; PEG/POE alkyl ethers
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
- A61K47/16—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing nitrogen, e.g. nitro-, nitroso-, azo-compounds, nitriles, cyanates
- A61K47/18—Amines; Amides; Ureas; Quaternary ammonium compounds; Amino acids; Oligopeptides having up to five amino acids
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/0019—Injectable compositions; Intramuscular, intravenous, arterial, subcutaneous administration; Compositions to be administered through the skin in an invasive manner
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P33/00—Antiparasitic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P33/00—Antiparasitic agents
- A61P33/14—Ectoparasiticides, e.g. scabicides
Landscapes
- Health & Medical Sciences (AREA)
- Veterinary Medicine (AREA)
- Chemical & Material Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Public Health (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Epidemiology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Engineering & Computer Science (AREA)
- Oil, Petroleum & Natural Gas (AREA)
- Tropical Medicine & Parasitology (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Organic Chemistry (AREA)
- Dermatology (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Medicinal Preparation (AREA)
Abstract
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
RU2013103140/15A RU2578036C2 (en) | 2010-06-29 | 2011-06-29 | New injectable compositions of eprinomectin |
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US35966310P | 2010-06-29 | 2010-06-29 | |
US61/359,663 | 2010-06-29 |
Publications (2)
Publication Number | Publication Date |
---|---|
WO2012001083A2 WO2012001083A2 (en) | 2012-01-05 |
WO2012001083A3 true WO2012001083A3 (en) | 2012-05-24 |
Family
ID=44629174
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
PCT/EP2011/060969 WO2012001083A2 (en) | 2010-06-29 | 2011-06-29 | Novel eprinomectin injectable compositions |
Country Status (2)
Country | Link |
---|---|
RU (1) | RU2578036C2 (en) |
WO (1) | WO2012001083A2 (en) |
Families Citing this family (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO2014098623A1 (en) * | 2012-12-20 | 2014-06-26 | Alleva Animal Health Limited | Injectable eprinomectin formulation and anthelmintic use thereof |
BR112016006182B1 (en) * | 2013-09-30 | 2023-01-10 | Zoetis Services Llc | LONG-LASTING VETERINARY COMPOSITION AND ITS USES |
EP3023092A1 (en) * | 2014-11-20 | 2016-05-25 | Ceva Sante Animale | Eprinomectin parenteral compositions |
CN114651961A (en) * | 2022-03-25 | 2022-06-24 | 浙江科露宝食品有限公司 | Medical formula food thickening component and preparation method and application thereof |
Citations (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO1997026895A1 (en) * | 1996-01-29 | 1997-07-31 | Gene Komer | Avermectin formulation |
US20070042013A1 (en) * | 2005-08-19 | 2007-02-22 | Soll Mark D | Long acting injectable formulations |
US20080027011A1 (en) * | 2005-12-20 | 2008-01-31 | Hassan Nached | Homogeneous paste and gel formulations |
WO2009070687A1 (en) * | 2007-11-26 | 2009-06-04 | Merial Limited | Solvent systems for pour-on formulations for combating parasites |
Family Cites Families (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
SE434277B (en) | 1976-04-19 | 1984-07-16 | Merck & Co Inc | SET TO MAKE NEW ANTIHELMINTICALLY EFFECTIVE ASSOCIATIONS BY CULTIVATING STREPTOMYCS AVERMITILIS |
AU713580B2 (en) | 1995-09-25 | 1999-12-02 | Merial Ltd | Anthelmintic macrocyclic lactone compositions |
AR045142A1 (en) * | 2003-07-30 | 2005-10-19 | Novartis Ag | BUEN SABOR DUCTILE MASTICABLE VETERINARY COMPOSITION |
-
2011
- 2011-06-29 RU RU2013103140/15A patent/RU2578036C2/en active
- 2011-06-29 WO PCT/EP2011/060969 patent/WO2012001083A2/en active Application Filing
Patent Citations (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO1997026895A1 (en) * | 1996-01-29 | 1997-07-31 | Gene Komer | Avermectin formulation |
US20070042013A1 (en) * | 2005-08-19 | 2007-02-22 | Soll Mark D | Long acting injectable formulations |
US20080027011A1 (en) * | 2005-12-20 | 2008-01-31 | Hassan Nached | Homogeneous paste and gel formulations |
WO2009070687A1 (en) * | 2007-11-26 | 2009-06-04 | Merial Limited | Solvent systems for pour-on formulations for combating parasites |
Also Published As
Publication number | Publication date |
---|---|
WO2012001083A2 (en) | 2012-01-05 |
RU2578036C2 (en) | 2016-03-20 |
RU2013103140A (en) | 2014-08-10 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
EA201492011A1 (en) | ANHATIC PHARMACEUTICAL FORMULATIONS FOR LOCAL APPLICATION | |
CA2999253C (en) | Heterocyclic compounds and uses thereof | |
BR112018003595A2 (en) | 6-6 bicyclic aromatic ring substituted nucleoside analogs for use as prmt5 inhibitors | |
WO2016137235A3 (en) | Pharmaceutical composition for treating cancer comprising microrna as active ingredient | |
WO2008154642A3 (en) | Antibacterial agents | |
WO2009111653A3 (en) | Antiviral therapeutic agents | |
WO2013123215A3 (en) | Antiviral drugs for treatment of arenavirus infection | |
BR112019024747A2 (en) | fixed dose formulations | |
WO2014031438A3 (en) | SUBSTITUTED PHENYL SPLEEN TYROSINE KINASE (Syk) INHIBITORS | |
WO2009123776A3 (en) | Antiviral drugs for treatment of arenavirus infection | |
WO2014019908A3 (en) | Substituted pyrroles active as kinases inhibitors | |
BR112014021531A8 (en) | compound, pharmaceutical composition and uses thereof | |
WO2012047587A3 (en) | Mdm2 inhibitors for treatment of ocular conditions | |
WO2012001083A3 (en) | Novel eprinomectin injectable compositions | |
WO2011160024A3 (en) | Compounds useful as antiviral agents, compositions, and methods of use | |
EP3417853A4 (en) | Pharmaceutical composition for treatment of cancer, containing polyphenol compound as active ingredient | |
EA201070691A1 (en) | AMIDA CONNECTIONS AS AN ACTIVATORS OF ANTI-VIRUS DRUGS | |
WO2013134534A3 (en) | Solid state forms of cabazitaxel and processes for preparation thereof | |
WO2012024405A3 (en) | Curcumin compositions and uses thereof | |
WO2012050641A3 (en) | Use of trpa1 antagonists to prevent or treat infections caused by biological-warfare agents | |
AR064152A1 (en) | ANTIBACTERIAL QUINOLINE DERIVATIVES, PHARMACEUTICAL COMPOSITIONS THAT CONTAIN THEM AND PREPARATION METHOD. | |
WO2012061012A3 (en) | 4-amino-2h-pyran-2-one analogs as anticancer agents | |
PH12017502426A1 (en) | Solid pharmaceutical compositions for treating hcv | |
WO2012122451A3 (en) | Polymorphs of maxacalcitol and process for the preparation of maxacalcitol | |
PH12018500132A1 (en) | Solid pharmaceutical compositions for treating hcv |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
121 | Ep: the epo has been informed by wipo that ep was designated in this application |
Ref document number: 11737914 Country of ref document: EP Kind code of ref document: A2 |
|
WWE | Wipo information: entry into national phase |
Ref document number: 2012/13789 Country of ref document: TR |
|
NENP | Non-entry into the national phase |
Ref country code: DE |
|
ENP | Entry into the national phase |
Ref document number: 2013103140 Country of ref document: RU Kind code of ref document: A |
|
122 | Ep: pct application non-entry in european phase |
Ref document number: 11737914 Country of ref document: EP Kind code of ref document: A2 |